back to top
Sunday, August 3, 2025
Tag:

Translational Research

Allen Institute Launches ...

On 15 May 2025, the Allen Institute unveiled CellScapes, an ambitious research initiative designed to transform our understanding of how human cells act in concert to assemble tissues and organs. Moving beyond traditional static snapshots, CellScapes will marry cutting-edge live-cell imaging with advanced computational modeling to reveal the underlying “rules of engagement” that govern individual and collective cell behaviors. By expressing these behaviors in precise mathematical terms, the project aims not only to predict but ultimately to design synthetic cell communities—“synthoids”—tailored for applications in regenerative medicine, cancer treatment and beyond.

NIH Study Uncovers How In...

A groundbreaking study by scientists at the National Institutes of Health (NIH) has unveiled the underlying biological mechanisms that cause normally harmless sensations like heat and touch to become painful in the presence of inflammation. The findings, published by researchers from the National Center for Complementary and Integrative Health (NCCIH) and the National Institute of Dental and Craniofacial Research (NIDCR), may open the door to more precise treatments for chronic and inflammatory pain.

Gut Microbiome Pattern Fo...

Scientists have identified a specific gut microbiota profile that can help forecast future heart attacks and major cardiovascular events in patients with coronary heart disease (CHD). The findings, published in the European Heart Journal, provide promising evidence that the gut microbiome may become a valuable tool in personalizing treatment and improving preventive strategies in cardiovascular care.

Older Adults Thrive on Im...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors, despite the natural weakening of the immune system that occurs with age. This promising conclusion comes from a new study conducted by researchers at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Convergence Institute.